Article
ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms.
Current hematologic malignancy reports - 1 Oct 2022
Sullivan Mia J, Palmer Elizabeth L, Botero Juliana Perez
Abstract excerpt
PURPOSE OF REVIEW: This review describes ANKRD26-related thrombocytopenia (RT) from a molecular, clinical, and laboratory perspective, with a focus on the clinical decision-making that takes place in the diagnosis and management of families with ANKRD26-RT. RECENT FINDINGS: ANKRD26-related thrombocytopenia (ANKRD26-RT) is a non-syndromic autosomal dominant thrombocytopenia with predisposition to hematologic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
